Skip to main content
Erschienen in: Strahlentherapie und Onkologie 8/2018

21.03.2018 | Original Article

Voxel-wise correlation of functional imaging parameters in HNSCC patients receiving PET/MRI in an irradiation setup

verfasst von: Kerstin Zwirner, M.D., Daniela Thorwarth, René M. Winter, Stefan Welz, Jakob Weiss, Nina F. Schwenzer, Holger Schmidt, Christian la Fougère, Konstantin Nikolaou, Daniel Zips, Sergios Gatidis

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this study was to demonstrate the feasibility of voxel-wise multiparametric characterization of head and neck squamous cell carcinomas (HNSCC) using hybrid multiparametric magnetic resonance imaging and positron emission tomography with [18F]-fluorodesoxyglucose (FDG-PET/MRI) in a radiation treatment planning setup.

Methods

Ten patients with locally advanced HNSCC were examined with a combined FDG-PET/MRI in an irradiation planning setup. The multiparametric imaging protocol consisted of FDG-PET, T2-weighted transverse short tau inversion recovery sequence (STIR) and diffusion-weighted MRI (DWI). Primary tumours were manually segmented and quantitative imaging parameters were extracted. PET standardized uptake values (SUV) and DWI apparent diffusion coefficients (ADC) were correlated on a voxel-wise level.

Results

Images acquired in this specialised radiotherapy planning setup achieved good diagnostic quality. Median tumour volume was 4.9 [1.1–42.1] ml. Mean PET SUV and ADC of the primary tumours were 5 ± 2.5 and 1.2 ± 0.3 10−3 mm2/s, respectively. In voxel-wise correlation between ADC values and corresponding FDG SUV of the tumours, a significant negative correlation was observed (r = −0.31 ± 0.27, p < 0.05).

Conclusion

Multiparametric voxel-wise characterization of HNSCC is feasible using combined PET/MRI in a radiation planning setup. This technique may provide novel insights into tumour biology with regard to radiation therapy in the future.
Literatur
8.
Zurück zum Zitat Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, Wang HM, Wong HF (2005) 18 F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med 46(7):1136–1143PubMed Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, Wang HM, Wong HF (2005) 18 F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med 46(7):1136–1143PubMed
17.
Zurück zum Zitat Minn H, Clavo AC, Grenman R, Wahl RL (1995) In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L‑methionine in squamous-cell carcinoma of the head and neck. J Nucl Med 36(2):252–258PubMed Minn H, Clavo AC, Grenman R, Wahl RL (1995) In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L‑methionine in squamous-cell carcinoma of the head and neck. J Nucl Med 36(2):252–258PubMed
19.
Zurück zum Zitat Fruehwald-Pallamar J, Czerny C, Mayerhoefer ME, Halpern BS, Eder-Czembirek C, Brunner M, Schuetz M, Weber M, Fruehwald L, Herneth AM (2011) Functional imaging in head and neck squamous cell carcinoma: correlation of PET/CT and diffusion-weighted imaging at 3 T. Eur J Nucl Med Mol Imaging 38(6):1009–1019. https://doi.org/10.1007/s00259-010-1718-4 CrossRefPubMed Fruehwald-Pallamar J, Czerny C, Mayerhoefer ME, Halpern BS, Eder-Czembirek C, Brunner M, Schuetz M, Weber M, Fruehwald L, Herneth AM (2011) Functional imaging in head and neck squamous cell carcinoma: correlation of PET/CT and diffusion-weighted imaging at 3 T. Eur J Nucl Med Mol Imaging 38(6):1009–1019. https://​doi.​org/​10.​1007/​s00259-010-1718-4 CrossRefPubMed
20.
21.
Zurück zum Zitat Nakajo M, Nakajo M, Kajiya Y, Tani A, Kamiyama T, Yonekura R, Fukukura Y, Matsuzaki T, Nishimoto K, Nomoto M, Koriyama C (2012) FDG PET/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient. Clin Nucl Med 37(5):475–480. https://doi.org/10.1097/RLU.0b013e318248524a CrossRefPubMed Nakajo M, Nakajo M, Kajiya Y, Tani A, Kamiyama T, Yonekura R, Fukukura Y, Matsuzaki T, Nishimoto K, Nomoto M, Koriyama C (2012) FDG PET/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient. Clin Nucl Med 37(5):475–480. https://​doi.​org/​10.​1097/​RLU.​0b013e318248524a​ CrossRefPubMed
26.
Zurück zum Zitat Aramburu Nunez D, Lopez Medina A, Mera Iglesias M, Gomez SF, Dave A, Hatzoglou V, Paudyal R, Calzado A, Deasy JO, Shukla-Dave A, Munoz VM (2017) Multimodality functional imaging using DW-MRI and 18 F-FDG-PET/CT during radiation therapy for human papillomavirus negative head and neck squamous cell carcinoma: Meixoeiro Hospital of Vigo Experience. World J Radiol 9(1):17–26. https://doi.org/10.4329/wjr.v9.i1.17 CrossRefPubMedPubMedCentral Aramburu Nunez D, Lopez Medina A, Mera Iglesias M, Gomez SF, Dave A, Hatzoglou V, Paudyal R, Calzado A, Deasy JO, Shukla-Dave A, Munoz VM (2017) Multimodality functional imaging using DW-MRI and 18 F-FDG-PET/CT during radiation therapy for human papillomavirus negative head and neck squamous cell carcinoma: Meixoeiro Hospital of Vigo Experience. World J Radiol 9(1):17–26. https://​doi.​org/​10.​4329/​wjr.​v9.​i1.​17 CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Schmidt H, Brendle C, Schraml C, Martirosian P, Bezrukov I, Hetzel J, Muller M, Sauter A, Claussen CD, Pfannenberg C, Schwenzer NF (2013) Correlation of simultaneously acquired diffusion-weighted imaging and 2‑deoxy-[18 F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system. Invest Radiol 48(5):247–255. https://doi.org/10.1097/RLI.0b013e31828d56a1 CrossRefPubMed Schmidt H, Brendle C, Schraml C, Martirosian P, Bezrukov I, Hetzel J, Muller M, Sauter A, Claussen CD, Pfannenberg C, Schwenzer NF (2013) Correlation of simultaneously acquired diffusion-weighted imaging and 2‑deoxy-[18 F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system. Invest Radiol 48(5):247–255. https://​doi.​org/​10.​1097/​RLI.​0b013e31828d56a1​ CrossRefPubMed
28.
Zurück zum Zitat Gatidis S, Graf H, Weiss J, Stemmer A, Kiefer B, Nikolaou K, Notohamiprodjo M, Martirosian P (2017) Diffusion-weighted echo planar MR imaging of the neck at 3 T using integrated shimming: comparison of MR sequence techniques for reducing artifacts caused by magnetic-field inhomogeneities. MAGMA 30(1):57–63. https://doi.org/10.1007/s10334-016-0582-z CrossRefPubMed Gatidis S, Graf H, Weiss J, Stemmer A, Kiefer B, Nikolaou K, Notohamiprodjo M, Martirosian P (2017) Diffusion-weighted echo planar MR imaging of the neck at 3 T using integrated shimming: comparison of MR sequence techniques for reducing artifacts caused by magnetic-field inhomogeneities. MAGMA 30(1):57–63. https://​doi.​org/​10.​1007/​s10334-016-0582-z CrossRefPubMed
Metadaten
Titel
Voxel-wise correlation of functional imaging parameters in HNSCC patients receiving PET/MRI in an irradiation setup
verfasst von
Kerstin Zwirner, M.D.
Daniela Thorwarth
René M. Winter
Stefan Welz
Jakob Weiss
Nina F. Schwenzer
Holger Schmidt
Christian la Fougère
Konstantin Nikolaou
Daniel Zips
Sergios Gatidis
Publikationsdatum
21.03.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 8/2018
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-018-1292-4

Weitere Artikel der Ausgabe 8/2018

Strahlentherapie und Onkologie 8/2018 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.